Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Juvenile rheumatoid arthritis.

K T Gallagher1, B Bernstein

  • 1Childrens Hospital Los Angeles, University of Southern California School of Medicine, 90027, USA.

Current Opinion in Rheumatology
|September 30, 1999
PubMed
Summary

Recent research defines juvenile rheumatoid arthritis (JRA) heterogeneity, linking cytokine profiles to disease subtypes and identifying therapeutic advances. Key findings include etanercept efficacy and methotrexate

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvir.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Counterpoint: is technology overemphasized?

IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society·2009
Same author

Sustainability. USGS goals for the coming decade.

Science (New York, N.Y.)·2007
Same author

Treatment of collagen induced arthritis in DBA/1 mice with L-asparaginase.

Clinical and experimental rheumatology·2002
Same author

A new cervical spine clearance protocol using computed tomography.

The Journal of trauma·2001
Same author

Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis.

The Journal of rheumatology·2001

Area of Science:

  • Rheumatology
  • Immunology
  • Pediatrics

Background:

  • Juvenile rheumatoid arthritis (JRA) is a heterogeneous autoimmune disease.
  • Understanding its varied pathogenesis and treatment responses is crucial for pediatric rheumatology.

Purpose of the Study:

  • To synthesize recent scientific publications defining JRA heterogeneity.
  • To highlight advancements in understanding JRA pathogenesis and treatment.

Main Methods:

  • Review of scientific literature published within the past year concerning JRA.
  • Analysis of findings related to cytokine profiles, disease activity, and therapeutic interventions.

Main Results:

  • Systemic JRA associated with decreased IL-10 and soluble IL-6 receptor.
  • IL-4 may play an anti-inflammatory role in pauciarticular JRA.
  • Lower platelet activating factor acetylhydrolase in active JRA linked to atherogenesis risk.
  • Etanercept Phase 3 trial confirmed efficacy and safety.
  • Intra-articular steroids and methotrexate show efficacy.
  • Methotrexate hepatotoxicity risk factors identified.
  • Osteoclasts implicated in joint erosions.
  • Cyclosporine A, mycophenolate mofetil, and methotrexate effective for refractory uveitis.

Conclusions:

  • Recent publications significantly advance the understanding of JRA heterogeneity.
  • New insights into JRA pathogenesis and effective treatment strategies have emerged.
  • Continued research is vital for improving outcomes in pediatric rheumatic diseases.

Related Experiment Videos